Bibliografia DUOPAP

1. Abulafia O., Pezzullo J. C., Sherer D. M.: Performance of ThinPrep liquid-based cervical cytology in comparison with conventionally prepared Papanicolau smears: a quantitative survey. Gynecologic Oncology 2003; 90: 137-144.
2. Almong B., Gamzu R., et al: Clinical and economic benefit of HPV-load testing in follow-up and management of women postcone biopsy for CIN2-3 Br. J. Cancer. 2003; 89 (1): 109-12.
3. Boselli F.: linee Guida edizione 2002 della SICPCV. La Colposcopia in italia, 2002: 1.
4. Boselli F.: Colposcopia e patologia del tratto genitale inferiore. Critical Medicin Publishing, Roma 2003.
5. Centers for Disease Control and Prevention. 1998 Guidelines for treatment of sexually transmitted disease. Morbid.Mortal.Weekly Rep. 1998;47(RR-1):1-11.
6. Ferenczy A., Franco E., et al: Diagnostic performance of Hybrid capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am. J. Obstet. Gynecol. 1996; 175: 651-6.
7. Gravitt P. E., Burk R. D., et al: A comparison between real time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomarkers. Prev. 2003; 12 (6): 477-84.
8. Ronco G., Ghisetti V, Segnan N., et al: Prevalence of Human papillomavirus infecition in women in Turin, Italy. EurJCancer, 2005; 41 (2): 297-305.
9. Sashebali S., Depuydt CE., Segers K., et coll: P16INK4a as an adjunct marker in liquid-base cervical cytology. Int. J. Cancer. 2004; 108: 871-876.
10. Schlecht N. F., Trevisan A., et al: Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int. J. Cancer.2003; 103 (4): 519-24.
11. Silins I., Ryd W., Strnd A., et al: Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer. 2005 in press.
12. Smith J. S., Boosteth C., Munoz N., et coll: Chlamydia trachomatis and invasive cdrvical cancer: a pooled analysis of the IARC multicentric case-control study. Int J cancer 2004. 111 (3): 431-439.
13. Szoke K., Sapy T., et al: Moderate variation of the oncogenic potential among high risk human papillomavirus types in gynecologic patients with cervical abnormalities. J.Med.Virol, 2003; 71 (4): 585-92.
14. The 2001 Bethesda System. Terminology for reporting results of Cervical Cytology. JAMA, 2002; 287: 2114.
15. Weissenbacher E. R., Schneider A., et al: Reccomandation for the diagnosis and treatment of HPV infections of the female tract. ESIDOG J. 2001Jun; 4/5 (suppl 2): 5-12.
16. Wright T., Cox J. T., Massad L. S., et coll: Algorithms from the consensus guidelines for the management of women with cervical cytological abnormalities JAMA 2002; 287: 2120-2129.